A New Alternative For Product
Commercialization
Commercialization
There used to be three primary options for product commercialization: co-promotion arrangement, self-commercialization, or out licensing the product. Now there is a fourth option: Interpace BioPharma, LLC (IBP).
We provide you with a complete and customized commercial infrastructure designed to successfully bring your product to market without giving up a large share of economic value or losing promotional control.
Whether you have a pharmaceutical, biotech, medical device, or diagnostic product that is established in the US or new to the market, Interpace BioPharma can help you achieve commercial success.